Assisted fundraising

Log in  |  Sign up

  • Home
  • Guides
  • Assets
  • Investors
    • VC funds
    • Tailored lists
    • Favorites
  • Academy
  • Privacy policy
    • Terms of Use
    • Privacy Policy
  • Help center
  • Return to waveup.com

Fund profile

3E Bioventures

3E Bioventures

China

Leading

About

3E Bioventures Capital is a prominent venture capital firm specializing in the life sciences sector, focusing on innovative therapeutic drugs and disruptive med-tech. Founded with a mission encapsulated in their name—Expertise, Efficiency, Execution—3E Bioventures actively invests in global health innovators and TechBio, aiming to disrupt conventional paradigms by integrating biology with technology​​. Notable investments include Aravive, which develops biologic drugs targeting tumor metastasis, and C4 Therapeutics, which pioneers small-molecule drugs that degrade disease-causing proteins. Their portfolio also boasts companies like Cytek, which offers a transformative flow cytometry platform, and Twist Bioscience, known for its advanced DNA synthesis technology​​. Geographically, 3E Bioventures operates with a global perspective, maintaining a strong presence in the US and China. They often participate in early-stage and growth-stage investments, providing significant support in both capital and strategic guidance​​. The firm’s team includes experienced professionals such as Li Jing, Frank Yan, and Linda Liu, who leverage their deep industry knowledge to support portfolio companies effectively. They emphasize a science-driven, entrepreneur-friendly approach, working closely with research institutions and companies to address unmet medical needs​. For startups seeking investment, 3E Bioventures looks for breakthrough innovations in biotech and med-tech, focusing on areas with strong medical needs and the potential for significant impact. They prefer to engage with companies that align with their strategic goals and demonstrate a clear pathway to success​​.

Details

Round

Series A
Series B
Series C+
Seed

Previous Investments

AI & Deep Tech
Biotech
E-commerce & Retail
Energy & Utilities
Hardware. Robotics & IoT
Healthtech & Wellness
Legal & Professional services
Lifestyle
Other
Pharma
Sports & Fitness

Geo focus

East Asia
USA

Highlights

$4.7M

Historical average check

$600M

Historical max check

November 2024

Last investment date

54

Investments

Biotech

Hardware. Robotics & IoT

E-commerce & Retail

Pharma

Healthtech & Wellness

AI & Deep Tech

Legal & Professional services

Data & Analytics

Energy & Utilities

Other

Showing 0 lists

Filter by

Sort by

Contacts

Website

3ebiovc.com

Social

Lists that include this fund